Global (R)-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid market was valued at USD 28.4 million in 2025 and is projected to reach USD 67.8 million by 2034, exhibiting a remarkable CAGR of 9.0% during the forecast period.
(R)-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid, a critical chiral intermediate and the pharmacologically active enantiomer essential for pregabalin synthesis, has...